Developer docs
API playgroundTry for free, no card

Search company profiles

Eremid Genomic Services

Full company profile

uuid0002cb7

Namestring
Eremid Genomic Services
Legal namestring
Eremid® Genomic Services, LLC
Websiteurl
eremid.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Eremid Genomic Services is a contract research organization (CRO) headquartered at the North Carolina Research Campus in Kannapolis, NC, providing customized genomics research and clinical testing services across three verticals: AgBiotech, Food & Nutrition, and Human Health. The company operates a CLIA-certified (November 2022) and CAP-accredited (November 2023) genomics laboratory equipped with multiple best-in-class sequencing and analysis platforms, including Illumina NovaSeq X+, NextSeq 2000, iSeq 100, and iScan; PacBio Revio for long-read HiFi sequencing; Oxford Nanopore MinION; 10x Genomics Chromium X for single-cell and spatial genomics; Nanostring nCounter for multiplexed expression; and Thermo Fisher GeneTitan for automated microarrays. As a PacBio Certified Service Provider, Eremid offers up to 1,300 human whole genomes per year at 30x coverage following its 2023 Revio installation, supporting applications from de novo assembly and structural variant detection to population-scale clinical studies.

The company's revenue model is project-based contract research, with engagements covering experimental design, sample processing, sequencing, bioinformatics analysis, and final reporting under multi-year contracts at undisclosed custom pricing. Named customers include Immunis AI (large immunogenomic oncology clinical studies) and BCD Biosciences (genomics data delivery). Go-to-market is consultative and direct, supplemented by content marketing, conference presence (ASHG, Precision Health, Plant Genomics & Gene Editing Congress), and partnerships with technology providers including Semaphore Solutions for Labbit LIMS implementation. Eremid is backed by Coddle Creek Capital, which provided a $3 million venture capital round in July 2023 to fund sequencing expansion. Leadership includes Chairman John E. Allen, Jr. (also General Partner of Coddle Creek Capital), CBO Julian Abery, CSO Julien Curaba (PhD, 13+ years research experience), CFO Brian Smith, and Operations Director Becky Borst, with the company employing 11-50 staff.

Short descriptiontext

Eremid Genomic Services is a CLIA-certified, CAP-accredited genomics contract research organization based in Kannapolis, NC, providing multi-platform sequencing, bioinformatics, and clinical genomics services to AgBiotech, Food & Nutrition, and Human Health organizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKannapolis, United States
HQ citystring
Kannapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomics contract research, clinical genomics testing, bioinformatics analysis services, next-generation sequencing, agricultural genomics research
Industry6 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYAFAEAJAC
Genomic Testing & Genetic Evaluation Services
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-Health Services8000
Product category
Genomics Contract Research Services
Social media profiles2 records
Revenue model2 records
1Contract Research Services
TypeProfessional Services
Description

Customized contract research services for genomics applications. Projects range from simple to complex studies across AgBiotech, Food & Nutrition, and Human Health sectors. Revenue generated through project-based engagements that include expert consultancy, experimental design, sample processing, data analysis, and project reporting. Pricing tailored to specific scientific needs and scope of work.

eremid.com
2Clinical Genomics Testing
TypeProfessional Services
Description

CLIA-certified, CAP-accredited clinical genomics laboratory services. Provides clinical clients with best-in-class genomics analysis, exceptional quality data, and world-class scientific staff for molecular diagnostics development and clinical studies.

eremid.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Contract research services are priced based on specific project requirements, experimental design complexity, sample processing needs, and data analysis requirements. The company provides expert consultancy on timelines and level of investment during project scoping.

eremid.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Eremid Genomic Services is a contract research organization that delivers customized genomics research and clinical testing services from a CLIA-certified, CAP-accredited laboratory in Kannapolis, NC. The company offers tailored sequencing, bioinformatics, and clinical genomics solutions to organizations in AgBiotech, Food & Nutrition, and Human Health sectors, using multi-platform instrumentation including Illumina, PacBio, Oxford Nanopore, 10x Genomics, Nanostring, and Thermo Fisher systems. Services span the full project lifecycle from scientific consultation and experimental design through sample processing, sequencing, bioinformatics analysis, and final project reporting.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Up to 15-fold increase in long-read sequencing throughput
+2 more records
Product overview1 text field

Eremid Genomic Services is a contract research organization providing customized genomics research and clinical testing services. The company operates a unified service offering centered on its CLIA-certified, CAP-accredited genomics laboratory, which combines advanced sequencing platforms (Illumina NovaSeq X+, NextSeq 2000, iSeq 100, iScan; PacBio Revio; Oxford Nanopore MinION; 10x Genomics Chromium X; Nanostring nCounter; Thermo Fisher GeneTitan) with expert bioinformatics analysis. Services span three specialist sectors—AgBiotech, Food & Nutrition, and Human Health—organized around core capabilities in genomics services, clinical services, and bioinformatics services, all delivered through a six-step process from scientific consultation through to project report.

Product and service6 records
1Genomics Services
CategoryGenomics laboratory services
Description

Comprehensive genomics laboratory services including Illumina short-read sequencing, PacBio long-read HiFi sequencing, RNA sequencing, epigenetic services, and microbiome sequencing, delivered as customized contract research projects for research organizations.

2Clinical Genomics Services
CategoryClinical genomics testing
Description

CLIA-certified, CAP-accredited clinical genomics testing services for human health applications, supporting development of molecular diagnostics and clinical studies with regulatory-grade quality data.

3Bioinformatics Services
CategoryBioinformatics analysis
Description

Fully customizable bioinformatics analysis services including de novo or guided genome assembly and finishing, gene model prediction and annotation, and methylation density analysis.

4AgBiotech Research Services
CategorySector-specific contract research
Description

Specialized contract research services for agricultural biotechnology organizations, including plant and animal microbiome studies, crop protection research, plant characterization, and trait discovery to support crop research addressing climate change and population expansion.

5Food & Nutrition Research Services
CategorySector-specific contract research
Description

Contract research services assessing the impact of foods, supplements, and nutrients on metabolism, including biomarker assessment, influence of diet on health studies, and nutrigenomics research.

6Human Health Research Services
CategorySector-specific contract research
Description

Comprehensive human health genomics contract research services including immuno-oncology research, drug discovery and development, molecular diagnostic method development, human microbiome research, cancer research, and pre-clinical population studies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Semaphore Solutions
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-11-15
Description

Strategic partnership for implementation of Labbit LIMS across Eremid's research, clinical, and training labs. Labbit is a next-generation Laboratory Information Management System designed to evolve as science advances, built with FAIR data principles and full data provenance. The partnership advances Eremid's end-to-end clinical genomics services, streamlines workflows, simplifies project management, and enhances collaboration capabilities while aligning with CLIA quality standards.

eremid.com
Strategic tierCoreTypeTechnology or Integration
Description

Eremid is a PacBio certified service provider offering HiFi sequencing as part of comprehensive genomics and bioinformatics services. Installation of PacBio Revio system provides up to 15-fold increase in long-read sequencing throughput, enabling larger-scale studies and novel applications in clinical genomics and agbiotech. PacBio collaboration enables detection of all types of genetic variations including large structural variants with remarkable precision.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Daicel Arbor Biosciences
TypeEmerging player
Description

Arbor Biosciences offers targeted sequencing, myTags capture, and PacBio-based services for agbiotech and biomedical customers — comparable in scale and overlapping in long-read, agbiotech, and bioinformatic capabilities.

TypeDirect peer
Description

Novogene is a leading global genomics CRO with Illumina and PacBio platforms serving academic, agricultural, and clinical customers; comparable multi-platform play with an explicit genomics services focus similar to Eremid.

TypeBroad incumbent
Description

BGI operates one of the world's largest sequencing operations (DNBSEQ and others) covering clinical, agricultural, and human health — competes with Eremid across NGS services and bioinformatics at hyperscale.

TypeBroad incumbent
Description

NeoGenomics is a US clinical oncology and molecular diagnostics lab serving hospital and pharma customers with CLIA/CAP-certified testing — overlaps Eremid's clinical genomics services for pharma/biotech sponsors at much greater scale.

TypeBroad incumbent
Description

Eurofins Genomics is the genomics arm of the global Eurofins testing network, providing NGS, Sanger, oligonucleotides, and bioinformatics across pharma, food, and agbiotech — overlapping with Eremid across all three of its served verticals as a much larger incumbent.

TypeDirect peer
Description

LC Sciences provides NGS, PacBio long-read, single-cell, and bioinformatics services across human health and agricultural research — a closely analogous multi-platform genomics CRO.

TypeDirect peer
Description

CD Genomics is an Illumina and PacBio NGS services CRO offering sequencing, bioinformatics, and assembly services to agbiotech and biomedical customers — directly comparable to Eremid's service mix and customer base.

TypeDirect peer
Description

Azenta acquired Genewiz in 2018 and operates the leading multi-platform genomics services business in the US, offering Sanger, NGS (Illumina + PacBio), and synthesis services to pharma and academic customers — directly competing with Eremid's core NGS CRO offering at significantly larger scale.

TypeEmerging player
Description

Zymo Research is a niche genomics tools and services provider offering extraction kits, microbiome sequencing, and analysis services for agbiotech and human microbiome customers — comparable to Eremid's microbiome and agbiotech service lines.

TypeDirect peer
Description

Omega Bioservices is a US-based genomics services CRO within the Omega Healthcare group offering NGS, Sanger, and bioinformatics for clinical and research customers — overlapping mid-market positioning with Eremid.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eremid Genomic Services

Genomics Contract Research Serviceseremid.com

Eremid Genomic Services is a CLIA-certified, CAP-accredited genomics contract research organization based in Kannapolis, NC, providing multi-platform sequencing, bioinformatics, and clinical genomics services to AgBiotech, Food & Nutrition, and Human Health organizations.

What Eremid Genomic Services does

Eremid Genomic Services is a contract research organization (CRO) headquartered at the North Carolina Research Campus in Kannapolis, NC, providing customized genomics research and clinical testing services across three verticals: AgBiotech, Food & Nutrition, and Human Health. The company operates a CLIA-certified (November 2022) and CAP-accredited (November 2023) genomics laboratory equipped with multiple best-in-class sequencing and analysis platforms, including Illumina NovaSeq X+, NextSeq 2000, iSeq 100, and iScan; PacBio Revio for long-read HiFi sequencing; Oxford Nanopore MinION; 10x Genomics Chromium X for single-cell and spatial genomics; Nanostring nCounter for multiplexed expression; and Thermo Fisher GeneTitan for automated microarrays. As a PacBio Certified Service Provider, Eremid offers up to 1,300 human whole genomes per year at 30x coverage following its 2023 Revio installation, supporting applications from de novo assembly and structural variant detection to population-scale clinical studies.

The company's revenue model is project-based contract research, with engagements covering experimental design, sample processing, sequencing, bioinformatics analysis, and final reporting under multi-year contracts at undisclosed custom pricing. Named customers include Immunis AI (large immunogenomic oncology clinical studies) and BCD Biosciences (genomics data delivery). Go-to-market is consultative and direct, supplemented by content marketing, conference presence (ASHG, Precision Health, Plant Genomics & Gene Editing Congress), and partnerships with technology providers including Semaphore Solutions for Labbit LIMS implementation. Eremid is backed by Coddle Creek Capital, which provided a $3 million venture capital round in July 2023 to fund sequencing expansion. Leadership includes Chairman John E. Allen, Jr. (also General Partner of Coddle Creek Capital), CBO Julian Abery, CSO Julien Curaba (PhD, 13+ years research experience), CFO Brian Smith, and Operations Director Becky Borst, with the company employing 11-50 staff.

Eremid Genomic Services firmographics

Firmographics
Name
Eremid Genomic Services
Legal name
Eremid® Genomic Services, LLC
Website
https://eremid.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Eremid Genomic Services is a CLIA-certified, CAP-accredited genomics contract research organization based in Kannapolis, NC, providing multi-platform sequencing, bioinformatics, and clinical genomics services to AgBiotech, Food & Nutrition, and Human Health organizations.
Ownership category
akta.pro rank

Eremid Genomic Services industry classification

Industry
Product category
Genomics Contract Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYAFAEAJAC
Genomic Testing & Genetic Evaluation Services

Keywords

  • Genomics contract research
  • Clinical genomics testing
  • Bioinformatics analysis services
  • Next-generation sequencing
  • Agricultural genomics research

Where Eremid Genomic Services is headquartered

Location

Headquarters

HQ city
Kannapolis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Eremid Genomic Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Research Services: Customized contract research services for genomics applications. Projects range from simple to complex studies across AgBiotech, Food & Nutrition, and Human Health sectors. Revenue generated through project-based engagements that include expert consultancy, experimental design, sample processing, data analysis, and project reporting. Pricing tailored to specific scientific needs and scope of work.
  2. Clinical Genomics Testing: CLIA-certified, CAP-accredited clinical genomics laboratory services. Provides clinical clients with best-in-class genomics analysis, exceptional quality data, and world-class scientific staff for molecular diagnostics development and clinical studies.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Distribution channels1 record

Marketing channels6 records

Eremid Genomic Services product offering

Product offering

Core offering

Eremid Genomic Services is a contract research organization that delivers customized genomics research and clinical testing services from a CLIA-certified, CAP-accredited laboratory in Kannapolis, NC. The company offers tailored sequencing, bioinformatics, and clinical genomics solutions to organizations in AgBiotech, Food & Nutrition, and Human Health sectors, using multi-platform instrumentation including Illumina, PacBio, Oxford Nanopore, 10x Genomics, Nanostring, and Thermo Fisher systems. Services span the full project lifecycle from scientific consultation and experimental design through sample processing, sequencing, bioinformatics analysis, and final project reporting.

Product overview

Eremid Genomic Services is a contract research organization providing customized genomics research and clinical testing services. The company operates a unified service offering centered on its CLIA-certified, CAP-accredited genomics laboratory, which combines advanced sequencing platforms (Illumina NovaSeq X+, NextSeq 2000, iSeq 100, iScan; PacBio Revio; Oxford Nanopore MinION; 10x Genomics Chromium X; Nanostring nCounter; Thermo Fisher GeneTitan) with expert bioinformatics analysis. Services span three specialist sectors—AgBiotech, Food & Nutrition, and Human Health—organized around core capabilities in genomics services, clinical services, and bioinformatics services, all delivered through a six-step process from scientific consultation through to project report.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genomics Services Comprehensive genomics laboratory services including Illumina short-read sequencing, PacBio long-read HiFi sequencing, RNA sequencing, epigenetic services, and microbiome sequencing, delivered as customized contract research projects for research organizations.
  • Clinical Genomics Services CLIA-certified, CAP-accredited clinical genomics testing services for human health applications, supporting development of molecular diagnostics and clinical studies with regulatory-grade quality data.
  • Bioinformatics Services Fully customizable bioinformatics analysis services including de novo or guided genome assembly and finishing, gene model prediction and annotation, and methylation density analysis.
  • AgBiotech Research Services Specialized contract research services for agricultural biotechnology organizations, including plant and animal microbiome studies, crop protection research, plant characterization, and trait discovery to support crop research addressing climate change and population expansion.
  • Food & Nutrition Research Services Contract research services assessing the impact of foods, supplements, and nutrients on metabolism, including biomarker assessment, influence of diet on health studies, and nutrigenomics research.
  • Human Health Research Services Comprehensive human health genomics contract research services including immuno-oncology research, drug discovery and development, molecular diagnostic method development, human microbiome research, cancer research, and pre-clinical population studies.

Quantifiable outcome

  • Up to 15-fold increase in long-read sequencing throughput
  • +2 more outcomes

Companies that use Eremid Genomic Services

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Eremid Genomic Services technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Eremid Genomic Services partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Semaphore SolutionscoreTechnology or Integration · 15 November 2023Strategic partnership for implementation of Labbit LIMS across Eremid's research, clinical, and training labs. Labbit is a next-generation Laboratory Information Management System designed to evolve as science advances, built with FAIR data principles and full data provenance. The partnership advances Eremid's end-to-end clinical genomics services, streamlines workflows, simplifies project management, and enhances collaboration capabilities while aligning with CLIA quality standards.
  • PacBiocoreTechnology or IntegrationEremid is a PacBio certified service provider offering HiFi sequencing as part of comprehensive genomics and bioinformatics services. Installation of PacBio Revio system provides up to 15-fold increase in long-read sequencing throughput, enabling larger-scale studies and novel applications in clinical genomics and agbiotech. PacBio collaboration enables detection of all types of genetic variations including large structural variants with remarkable precision.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Eremid Genomic Services competitors and assessment

Company assessment

Emerging players

  • Daicel Arbor Biosciences: Arbor Biosciences offers targeted sequencing, myTags capture, and PacBio-based services for agbiotech and biomedical customers — comparable in scale and overlapping in long-read, agbiotech, and bioinformatic capabilities.
  • Zymo Research: Zymo Research is a niche genomics tools and services provider offering extraction kits, microbiome sequencing, and analysis services for agbiotech and human microbiome customers — comparable to Eremid's microbiome and agbiotech service lines.

Direct peers

  • Novogene: Novogene is a leading global genomics CRO with Illumina and PacBio platforms serving academic, agricultural, and clinical customers; comparable multi-platform play with an explicit genomics services focus similar to Eremid.
  • LC Sciences: LC Sciences provides NGS, PacBio long-read, single-cell, and bioinformatics services across human health and agricultural research — a closely analogous multi-platform genomics CRO.
  • CD Genomics: CD Genomics is an Illumina and PacBio NGS services CRO offering sequencing, bioinformatics, and assembly services to agbiotech and biomedical customers — directly comparable to Eremid's service mix and customer base.
  • Azenta Life Sciences (Genewiz): Azenta acquired Genewiz in 2018 and operates the leading multi-platform genomics services business in the US, offering Sanger, NGS (Illumina + PacBio), and synthesis services to pharma and academic customers — directly competing with Eremid's core NGS CRO offering at significantly larger scale.
  • Omega Bioservices: Omega Bioservices is a US-based genomics services CRO within the Omega Healthcare group offering NGS, Sanger, and bioinformatics for clinical and research customers — overlapping mid-market positioning with Eremid.

Broad incumbents

  • BGI Genomics: BGI operates one of the world's largest sequencing operations (DNBSEQ and others) covering clinical, agricultural, and human health — competes with Eremid across NGS services and bioinformatics at hyperscale.
  • NeoGenomics: NeoGenomics is a US clinical oncology and molecular diagnostics lab serving hospital and pharma customers with CLIA/CAP-certified testing — overlaps Eremid's clinical genomics services for pharma/biotech sponsors at much greater scale.
  • Eurofins Genomics: Eurofins Genomics is the genomics arm of the global Eurofins testing network, providing NGS, Sanger, oligonucleotides, and bioinformatics across pharma, food, and agbiotech — overlapping with Eremid across all three of its served verticals as a much larger incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Eremid Genomic Services social profiles

Digital presence

Eremid Genomic Services compliance and trust

Trust signal

Compliance2 records

Eremid Genomic Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eremid Genomic Services leadership team

Management profile

Number of profiles

Profiles5 records

Eremid Genomic Services funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eremid Genomic Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eremid Genomic Services

What does Eremid Genomic Services do?

Eremid Genomic Services is a contract research organization that delivers customized genomics research and clinical testing services from a CLIA-certified, CAP-accredited laboratory in Kannapolis, NC. The company offers tailored sequencing, bioinformatics, and clinical genomics solutions to organizations in AgBiotech, Food & Nutrition, and Human Health sectors, using multi-platform instrumentation including Illumina, PacBio, Oxford Nanopore, 10x Genomics, Nanostring, and Thermo Fisher systems. Services span the full project lifecycle from scientific consultation and experimental design through sample processing, sequencing, bioinformatics analysis, and final project reporting.

Is Eremid Genomic Services a public or private company?

Eremid Genomic Services is a private company. It is classified as venture growth investor backed and is currently operating.

When was Eremid Genomic Services founded?

Eremid Genomic Services was founded in 2019. It employs 11 to 50 people.

Where is Eremid Genomic Services based?

Eremid Genomic Services is headquartered in Kannapolis, United States, in the North America region.

How does Eremid Genomic Services make money?

Two revenue lines are on record. Contract Research Services are the primary driver. The others are clinical Genomics Testing.

Who are Eremid Genomic Services's main competitors?

Emerging players on record are Daicel Arbor Biosciences and Zymo Research. Direct peers are Novogene, LC Sciences, CD Genomics, Azenta Life Sciences (Genewiz) and Omega Bioservices. Broad incumbents are BGI Genomics, NeoGenomics and Eurofins Genomics.

Does Eremid Genomic Services have an API?

No public API is recorded for Eremid Genomic Services.

What industry is Eremid Genomic Services in?

Eremid Genomic Services's product category is Genomics Contract Research Services. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals